| | To ensure that you never miss an issue, please whitelist us. |
|
|
| | | The SIMPLE trial is a single-center, double-blind, randomized clinical trial evaluating the influence of empagliflozin on myocardial flow in high-risk patients with type 2 diabetes. The study involved 91 participants with known CVD or high CVD risk between April 2017 and May 2020. |
|
|
Recently, Diabetes has emerged as a considerable risk factor for adverse events in Covid-19 infection and hospitalization. Thus, the goal is to examine the relationship between diabetes and infection leading to hospitalization risk in the atherosclerosis risk in communities (ARIC) study. |
| | |
| |
| |
The study conducted by Mercado et al. analyzed data from patients with diabetes in rural and urban areas from 1999-2018. They specifically focused on four parameters: A1c, blood pressure, cholesterol, and smoking history (ABCS). Data for this study was collected from The National Health and Nutrition Examination Survey (NHANES). |
| | |
|
|
|
